Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses

Cell Reports - United States
doi 10.1016/j.celrep.2019.09.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

BRAF -V600 Mutational Status Affects Recurrence Patterns of Melanoma Brain Metastasis

International Journal of Cancer
Cancer ResearchOncology
2017English

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma

PLoS ONE
Multidisciplinary
2015English

Comparison of Responses of Human Melanoma Cell Lines to MEK and BRAF Inhibitors

Frontiers in Genetics
GeneticsMolecular Medicine
2013English

PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Genetic Variation in the Serotonin Receptor Gene Affects Immune Responses

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

Genetic Heterogeneity in Uveal Melanoma Assessed by Multiplex Ligation-Dependent Probe Amplification

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

BRAF,NRASandKITsequencing Analysis of Spindle Cell Melanoma

Journal of Cutaneous Pathology
DermatologyForensic MedicinePathologyHistology
2012English

BRAF G596R Mutation in a Slow-Progressing Melanoma

Pathology and Laboratory Medicine International
2015English

Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy